Medtronic Inc (MDT) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Medtronic Inc (MDT)

83.29

+0.09 (0.11%)

as of Jul 20, 2026, 8:00:00 pm Market Open.

182 watching

Investor Insights

Jul 20, 2026, 12:00 am

This summary was created by AI, based on 2 opinions in the last 12 months.

Medtronic Inc (MDT-N) has garnered a mix of opinions from experts. One expert sees the company benefiting from advancements in AI technologies, suggesting that boomers continuing to operate in the market serves as a tailwind for growth. Another expert expresses a more cautious outlook, highlighting that while MDT is currently experiencing a positive short- to medium-term phase and is positioned to compete strongly against peers like Boston Scientific, it may lack the research and development prowess to sustain its leadership over the long term. Despite being diversified in its product offerings, which is a strength compared to competitors focused solely on specific device categories, there are concerns about MDT's market position. Upcoming product launches and a perceived undervaluation, with the stock's price-to-earnings ratio being attractive, may support the stock for the next 12-18 months; however, the long-term outlook remains uncertain.

Consensus

Mixed

Valuation

Undervalued

Similar

SYK

TOP PICK

He has a model price of $41.29 giving it a 21% positive differential. Just reported greater earnings. 2% yield.

Wealthica Track your Stocks in your Watch List

BUY

Likes medical devices sector. Of all the sectors, medical equipment is one of the tops. Regardless of what is going on in the economies , medical devices will continue to sell. He owns Zoll Medical (ZOLL-Q) instead, which has more growth potential. Thinks there is more upside potential in the small/mid-cap size names.

BUY

PE of about 20 and anticipated growth rate of about 14%. Have a lot of intellectual property. Reasonably attractive.

DON'T BUY

His model price is $41.45 so it is a negative 23%-24% differential. This is one of those stocks that is perpetually overvalued.

BUY

Likes a lot of the big US healthcare stocks. Valuation is reasonable.

BUY ON WEAKNESS

On his watch list as a possible investment. Valuation has been hurt but the fundamentals have not changed much. The long-term outlook for their products is very good.

TOP PICK

A high quality, growth company. Good price. The leading medical technology company in the world.

TOP PICK

Solid earnings. Feels their new stent will be successful next year.

DON'T BUY

Interesting company. Market is very strong for their products. Stock isn't cheap. Has been growing slowely

DON'T BUY

Valuation is a little bit ahead of the stock. Very good management.

DON'T BUY

Competition. Too expensive at 30 X earnings.

BUY ON WEAKNESS

Great company. Buy in the mid to low $20's.

TOP PICK

Good company. Not a cheap stock. A cash machine.

BUY

Good price now. Good mngmnt.

PAST TOP PICK

Good acquisition. Fairly expensive, but the dominant player. No debt. Good dividends.

Showing 106 to 120 of 125 entries

Most Recent Experts

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

David Driscoll

Liberty International Investment Management Inc

Malcolm Ethridge, Mgn. partner, Capital Area Planning Group

Capital Area Planning Group

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Kevin Simpson

Capital Wealth Planning

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Medtronic Inc (MDT)